Archer-Daniels-Midland (ADM)
NYSE: ADM
· Real-Time Price · USD
62.95
1.01 (1.63%)
At close: Sep 05, 2025, 3:59 PM
63.09
0.22%
After-hours: Sep 05, 2025, 07:55 PM EDT
Archer-Daniels-Midland Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ag Services and Oilseeds Revenue | 15.68B | 16.88B | 15.09B | 17.33B | 17.22B | 22.56B | 16.48B | 19.84B | 18.58B | 24.86B | 19.14B | 21.43B | 18.25B | 21.49B | 15.69B | 18.27B | 15.01B | 20.32B | 11.53B | 12.74B | 11.08B | 42.02B | 12.62B | 2.44B | 2.4B | 3.6B | 2.53B | 2.67B | 2.62B |
| Ag Services and Oilseeds Revenue Growth | -7.11% | +11.84% | -12.95% | +0.66% | -23.66% | +36.88% | -16.96% | +6.81% | -25.27% | +29.89% | -10.68% | +17.40% | -15.05% | +36.96% | -14.13% | +21.75% | -26.15% | +76.28% | -9.53% | +15.00% | -73.63% | +233.05% | +416.84% | +1.58% | -33.19% | +41.95% | -5.02% | +1.75% | n/a |
| Carbohydrate Solutions Revenue | 2.57B | 2.75B | 2.91B | 2.89B | 2.68B | 4.3B | 3.33B | 3.38B | 3.54B | 5.64B | 3.58B | 3.75B | 3.37B | 4.76B | 2.87B | 2.82B | 2.22B | 3.03B | 2.06B | 2.01B | 2.32B | 3.75B | 2.56B | 1.52B | 1.28B | 945M | 922M | 1.02B | 950M |
| Carbohydrate Solutions Revenue Growth | -6.48% | -5.47% | +0.48% | +7.86% | -37.55% | +29.20% | -1.66% | -4.41% | -37.26% | +57.44% | -4.53% | +11.44% | -29.33% | +66.19% | +1.63% | +26.86% | -26.61% | +46.75% | +2.48% | -13.04% | -38.16% | +46.00% | +68.31% | +18.88% | +35.66% | +2.49% | -9.43% | +7.16% | n/a |
| Nutrition Revenue | 1.82B | 1.77B | 1.83B | 1.91B | 1.84B | 1.98B | 1.78B | 1.85B | 1.85B | 2.04B | 1.86B | 2B | 1.92B | 1.94B | 1.7B | 1.73B | 1.56B | 1.6B | 1.45B | 1.44B | 1.47B | 1.52B | 1.46B | n/a | n/a | n/a | n/a | n/a | n/a |
| Nutrition Revenue Growth | +2.42% | -3.11% | -4.04% | +3.92% | -7.09% | +10.76% | -3.72% | 0.00% | -9.39% | +9.71% | -6.94% | +4.11% | -0.82% | +14.32% | -2.08% | +10.88% | -2.31% | +10.27% | +0.97% | -2.31% | -3.41% | +4.53% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Revenue | 78M | 62M | 67M | 63M | 76M | 73M | 25M | 122M | 63M | 44M | 72M | 77M | 85M | 74M |
| Asia Revenue Growth | +25.81% | -7.46% | +6.35% | -17.11% | +4.11% | +192.00% | -79.51% | +93.65% | +43.18% | -38.89% | -6.49% | -9.41% | +14.86% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 895M | 932M | 943M | 905M | 907M | 951M | 919M | 815M | 841M | 881M | 897M | 818M | 814M | 829M | 786M | 720M | 739M | 749M | 749M | 636M | 638M | 664M | 654M | 578M | 602M | 659M | 558M | 534M | 560M | 513M | 463M | 478M | 525M | 516M | 470M | 546M | 500M | 479M | 482M | 519M | 525M | 498M |
| Selling, General, and Administrative Revenue Growth | -3.97% | -1.17% | +4.20% | -0.22% | -4.63% | +3.48% | +12.76% | -3.09% | -4.54% | -1.78% | +9.66% | +0.49% | -1.81% | +5.47% | +9.17% | -2.57% | -1.34% | 0.00% | +17.77% | -0.31% | -3.92% | +1.53% | +13.15% | -3.99% | -8.65% | +18.10% | +4.49% | -4.64% | +9.16% | +10.80% | -3.14% | -8.95% | +1.74% | +9.79% | -13.92% | +9.20% | +4.38% | -0.62% | -7.13% | -1.14% | +5.42% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |